Using MSA patients neuronal cells with and without the COQ2 mutation, Nakamoto et al. [24] identified evidence of cellular dysfunctions attributable to a decrease in CoQ10 status, which were in part resolved as the result of exogenous CoQ10 supplementation. The gene discussed is COQ2; the disease is multiple system atrophy.